Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.

Saved in:
Bibliographic Details
Title: Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Authors: Loriè, E. Pavez1, Cools, M.2, Borgers, M.1,2, Wouters, L.3, Shroot, B.4, Hagforsen, E.1, Törm, H.1, Vahlquist, A.1 anders.vahlquist@medsci.uu.se
Source: British Journal of Dermatology. Jan2009, Vol. 160 Issue 1, p26-36. 11p. 2 Diagrams, 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070963
DOI:10.1111/j.1365-2133.2008.08895.x